Società Advanced Proteome Therapeutics Corp. Other OTC
Azioni
CA0076281009
Società Holding
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16/04/18 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10/03/09 |
Martin Woodward
BRD | Director/Board Member | 56 | 20/12/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20/12/18 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21/11/22 |
Paul Woodward
CEO | Chief Executive Officer | 63 | 16/04/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 41 127 080 | 36 950 363 ( 89,84 %) | 0 | 89,84 % |
Coordinate società
Advanced Proteome Therapeutics Corp.
8337 Eastlake Drive Suite 104
V5A 4W2, Burnaby
+(604) 690-3797
![Indirizzo Advanced Proteome Therapeutics Corp.](https://cdn.zonebourse.com/static/address/196487.png)
Variaz. 1 gen. | Capi. | |
---|---|---|
+128,17% | 7,06 Mrd | |
+2,57% | 986 Mln | |
+41,91% | 883 Mln | |
+16,11% | 759 Mln | |
+2,11% | 666 Mln | |
+2,33% | 615 Mln | |
-.--% | 600 Mln | |
+8,61% | 528 Mln | |
-.--% | 500 Mln |